The increasing body of evidence supports that hypoxia-inducible factor 1 al
pha (HIF-1 alpha) a dominant subunit of HIF-1 heterodimer, is not solely in
duced by the effect of hypoxia. Apart from CoCl2 and iron chelators that se
rve as the putative HIF-1 alpha activators, genetic alterations and other e
pigenetic effects are able to induce HIF-1 alpha protein accumulation and t
o activate HIF-1 functions. Activation of oncogenes (H-ras and v-src) invol
ving signaling cascades (PI3K and MAPK) and loss-of-function mutations in t
umor suppressor genes (VHL, PTEN, and p53) result in HIF-1 alpha protein ac
cumulation and increased expression of downstream target genes. HIF-1 alpha
can also be induced by a number of agonists. Activation of HIF-1 alpha is
often an interactive consequence of multiple factors.